Approaches in High-Risk Non-Muscle Invasive Bladder Cancer
The evolving landscape in the management of high-risk non-muscle-invasive bladder cancer
Conversations in High-Risk Non-Muscle Invasive Bladder Cancer
High Grade Non Muscle Invasive Bladder Cancer: Stages and treatment including BCG
Expert video report on the management of patients with high-risk non-muscle invasive bladder cancer
A Multi-Disciplinary Care Model For Patients with Muscle Invasive Bladder Cancer
Controversies in Non-muscle Invasive Bladder Cancer (NMIBC): Guidelines and Beyond 2023
Yair Lotan, MD, shares outcomes of KEYNOTE 057 in high-risk non-muscle-invasive bladder cancer
New treatment of non-muscle-invasive bladder cancer
KEYTRUDA® For High-Risk Non-Muscle Invasive Bladder Cancer
BCG Unresponsive Non-Muscle Invasive Bladder Cancer
Management of Non Muscle Invasive Bladder Cancer Webcast (2021)
Understanding Types and Grades of Non-Muscle Invasive Bladder Cancer
Understanding Treatments for Non-Muscle Invasive Bladder Cancer
BCG Treatment for High Grade, Non-Muscle Invasive Bladder Cancer
Recurrence of Non Muscle Invasive Bladder Cancer
Staging and Standards of Care for Non Muscle Invasive Bladder Cancer
Treatment Paradigms for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer